WASHINGTON, Jan 4 (Reuters) - SGX Pharmaceuticals Inc., a biotechnology company, on Wednesday set its planned initial public offering at 4 million shares at an estimated price of $11 to $13 each.
WASHINGTON, Jan 4 (Reuters) - SGX Pharmaceuticals Inc., a biotechnology company, on Wednesday set its planned initial public offering at 4 million shares at an estimated price of $11 to $13 each.
